Senolytic Vaccines from the Central and Peripheral Tolerance Perspective.

Area of Science:

• Gerontology
• Immunology
• Preventive Medicine

Background:

• Vaccination is a highly effective preventive medical technology, saving numerous lives and successfully controlling infectious diseases.
• Increased life expectancy has led to a rise in age-associated diseases, creating a significant socio-economic burden.
• Senescent cells accumulate with age, contributing to age-related diseases and functional decline.

Purpose of the Study:

• To explore the potential of vaccine-based approaches for preventing or treating age-related diseases.
• To investigate the role of senescent cells in aging and the feasibility of targeting them with vaccines.
• To discuss immunological mechanisms that hinder the development of anti-senescent vaccines.

Main Methods:

• Review of existing literature on preventive medicine, vaccination, and aging.
• Analysis of the biological basis of senescent cell accumulation and its impact on health.
• Discussion of immunological tolerance mechanisms (central and peripheral) influencing anti-senescent immune responses.

Main Results:

• Eliminating senescent cells in animal models has shown functional restoration, rejuvenation, and life extension.
• Development of vaccines against senescent cells faces challenges due to antigenic heterogeneity and lack of unique markers.
• Self-originating senescent cells exhibit low immunogenicity, complicating vaccine design.

Conclusions:

• Vaccine-based strategies targeting senescent cells hold significant potential for promoting active longevity and economic benefits.
• Understanding and overcoming central and peripheral tolerance mechanisms are crucial for developing effective anti-senescent vaccines.
• Further research is needed to address the immunological hurdles in creating vaccines against senescent cells for age-related conditions.